Venous Disease Clinical Trials

9 recruitingLast updated: May 21, 2026

There are 9 actively recruiting venous disease clinical trials across 12 countries. Studies span Not Applicable, Phase 2. Top locations include Dallas, Texas, United States, Cleveland, Ohio, United States, Athens, Greece, Greece. Updated daily from ClinicalTrials.gov.


Venous Disease Trials at a Glance

9 actively recruiting trials for venous disease are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Dallas, Cleveland, and Athens. Lead sponsors running venous disease studies include Ekalab S.r.l., IRCCS San Raffaele, and Cleusa Ema Quilici Belczak.

Browse venous disease trials by phase

About Venous Disease Clinical Trials

Looking for clinical trials for Venous Disease? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Venous Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Venous Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Venous UlcerVenous StenosisVenous Occlusion+7 more
W.L.Gore & Associates165 enrolled27 locationsNCT05489588
Recruiting
Phase 2

Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases

Venous Diseases
Min Zhou50 enrolled1 locationNCT07452250
Recruiting

Vascular Lab Resource (VLR) Biorepository

LymphedemaCardiovascular DiseasesMetabolic Disease+13 more
The Cleveland Clinic500 enrolled1 locationNCT05628948
Recruiting
Not Applicable

Effects of a Dietary Supplement Composed of Diosmin, Hesperidin, Bromelain, and Ruscus Aculeatus on the Quality of Life in Subjects With Lower Limb Disorders Possibly Prodromal to Chronic Venous Disease

Prodromal to Chronic Venous Disease
Ekalab S.r.l.84 enrolled6 locationsNCT07185386
Recruiting

Reducing Skin Tone Inequities in Chronic Venous Insufficiency

Venous Leg Ulcer (VLU)Chronic Venous Insufficiency, CVIChronic Venous Insufficiency C2 or Higher+1 more
King's College London51 enrolled2 locationsNCT06798766
Recruiting
Not Applicable

Prospective Cohort Study on the Determinants of Venous THromboembolic Recurrence

Thromboembolic Venous Disease
University Hospital, Brest3,400 enrolled4 locationsNCT04297085
Recruiting

European Venous Registry

Deep Venous Disease of the Lower Limbs
IRCCS San Raffaele100 enrolled10 locationsNCT06906250
Recruiting

US Post-Market Surveillance Study of the Surfacer System

Venous Disease
Merit Medical Systems, Inc.30 enrolled6 locationsNCT05050799
Recruiting

Obesity and worsening of chronic venous disease and joint mobility

Chronic venous diseaseObesity
Cleusa Ema Quilici Belczak100 enrolled1 locationACTRN12610000761066